Bolt Biotherapeutics, Inc.
BOLT
$0.365
-$0.005-1.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.79% | 8.71% | 13.84% | 22.57% | 21.45% |
| Total Depreciation and Amortization | -3.94% | -1.46% | 0.99% | 3.89% | 11.28% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.49% | -6.70% | -12.92% | -31.48% | -40.84% |
| Change in Net Operating Assets | 14.44% | 53.15% | -77.58% | -34.70% | -222.67% |
| Cash from Operations | 11.85% | 16.51% | 8.59% | 16.82% | 9.12% |
| Capital Expenditure | 80.10% | 87.76% | 82.08% | 84.97% | 89.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -19.33% | -15.26% | -7.44% | 10.76% | 19.11% |
| Cash from Investing | -18.95% | -14.67% | -6.26% | 13.57% | 22.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -57.31% | -36.43% | -36.43% | -36.11% | -49.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -57.31% | -36.43% | -36.43% | -36.11% | -49.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -304.13% | 117.02% | 23.10% | 64.45% | 109.74% |